Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qiankun Chen & Ji Liu. (2018) Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity. International Journal of Nanomedicine 13, pages 6009-6018.
Read now
Read now
Najla M. Salkho, Vinod Paul, Pierre Kawak, Rute F. Vitor, Ana M. Martins, Mohammad Al Sayah & Ghaleb A. Husseini. (2018) Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 462-472.
Read now
Read now
Gang Li, Yan-zhi Song, Zhen-jun Huang, Kang Chen, Da-wei Chen & Yi-hui Deng. (2017) Novel, nano-sized, liposome-encapsulated polyamidoamine dendrimer derivatives facilitate tumour targeting by overcoming the polyethylene glycol dilemma and integrin saturation obstacle. Journal of Drug Targeting 25:8, pages 734-746.
Read now
Read now
Seyedeh Hoda Alavizadeh, Javad Akhtari, Ali Badiee, Shiva Golmohammadzadeh & Mahmoud Reza Jaafari. (2016) Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models. Expert Opinion on Drug Delivery 13:3, pages 325-336.
Read now
Read now
Articles from other publishers (18)
Elisabetta Mazzotta, Martina Romeo & Rita Muzzalupo. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery
135
159
.
Aliesha Moudgil, Rajesh Salve, Virendra Gajbhiye & Bhushan P. Chaudhari. (2023) Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum. Chemistry and Physics of Lipids 250, pages 105258.
Crossref
Crossref
Yike Jiang, Ziyi Jiang, Mingzhe Wang & Lan Ma. (2022) Current understandings and clinical translation of nanomedicines for breast cancer therapy. Advanced Drug Delivery Reviews 180, pages 114034.
Crossref
Crossref
Dalapathi Gugulothu & Dharmendra Kumar Khatri. 2022. Bionanotechnology : Emerging Applications of Bionanomaterials. Bionanotechnology : Emerging Applications of Bionanomaterials
129
185
.
Jafrin Jobayer Sonju, Achyut Dahal, Sitanshu S. Singh & Seetharama D. Jois. (2021) Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment. Journal of Controlled Release 329, pages 624-644.
Crossref
Crossref
Gautam Kumar, Krishnadas Nandakumar, Srinivas Mutalik & Chamallamudi Mallikarjuna Rao. (2020) Biologicals to direct nanotherapeutics towards HER2-positive breast cancers. Nanomedicine: Nanotechnology, Biology and Medicine 27, pages 102197.
Crossref
Crossref
Umme Hani, Mohamed Rahamathulla, Riyaz Ali Osmani, Honnavalli Yogish Kumar, Deeparani Urolagin, Mohammad Yousuf Ansari, Kamal Pandey, Keerthana Devi & Sabina Yasmin. (2020) Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review. Journal of Drug Delivery Science and Technology 56, pages 101505.
Crossref
Crossref
Wei Yan, Sharon SY Leung & Kenneth KW To. (2020) Updates on the use of liposomes for active tumor targeting in cancer therapy. Nanomedicine 15:3, pages 303-318.
Crossref
Crossref
A.L.B. Seynhaeve, M. Amin, D. Haemmerich, G.C. van Rhoon & T.L.M. ten Hagen. (2020) Hyperthermia and smart drug delivery systems for solid tumor therapy. Advanced Drug Delivery Reviews 163-164, pages 125-144.
Crossref
Crossref
Naseem Akhtar & Riaz A. Khan. (2016) Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'. Progress in Lipid Research 64, pages 192-230.
Crossref
Crossref
Shravan Kumar Sriraman, Giusseppina Salzano, Can Sarisozen & Vladimir Torchilin. (2016) Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid. European Journal of Pharmaceutics and Biopharmaceutics 105, pages 40-49.
Crossref
Crossref
Hiroshi Maeda, Kenji Tsukigawa & Jun Fang. (2016) A Retrospective 30?Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy-Problems, Solutions, and Prospects. Microcirculation 23:3, pages 173-182.
Crossref
Crossref
Antonella Accardo & Giancarlo Morelli. (2015) Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues. Biopolymers 104:5, pages 462-479.
Crossref
Crossref
David R. KhanMaggie N. WebbThomas H. CadotteMadison N. Gavette. (2015) Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer. Breast Cancer: Basic and Clinical Research 9s2, pages BCBCR.S29421.
Crossref
Crossref
Kacee H. Sims, Ewan M. Tytler, John Tipton, Kasey L. Hill, Stephen W. Burgess & Walter A. Shaw. (2014) Avanti lipid tools: Connecting lipids, technology, and cell biology. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1841:8, pages 1038-1048.
Crossref
Crossref
Shravan Kumar Sriraman & Vladimir P. Torchilin. 2014. Advanced Biomaterials and Biodevices. Advanced Biomaterials and Biodevices
79
119
.
Quanyin Hu, Xiaoling Gao, Ting Kang, Xingye Feng, Di Jiang, Yifan Tu, Qingxiang Song, Lei Yao, Xinguo Jiang, Hongzhuan Chen & Jun Chen. (2013) CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Biomaterials 34:37, pages 9496-9508.
Crossref
Crossref
Li Li, Timo L.M. ten Hagen, Martin Hossann, Regine Süss, Gerard C. van Rhoon, Alexander M.M. Eggermont, Dieter Haemmerich & Gerben A. Koning. (2013) Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. Journal of Controlled Release 168:2, pages 142-150.
Crossref
Crossref